FDMT
Price
$3.33
Change
-$0.01 (-0.30%)
Updated
Apr 28, 04:59 PM (EDT)
Capitalization
154.65M
10 days until earnings call
RGNX
Price
$9.13
Change
-$0.02 (-0.22%)
Updated
Apr 28, 04:59 PM (EDT)
Capitalization
458.57M
2 days until earnings call
Ad is loading...

FDMT vs RGNX

Header iconFDMT vs RGNX Comparison
Open Charts FDMT vs RGNXBanner chart's image
4D Molecular Therapeutics
Price$3.33
Change-$0.01 (-0.30%)
Volume$2.46K
Capitalization154.65M
REGENXBIO
Price$9.13
Change-$0.02 (-0.22%)
Volume$12.19K
Capitalization458.57M
FDMT vs RGNX Comparison Chart
Loading...
FDMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FDMT vs. RGNX commentary
Apr 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FDMT is a StrongBuy and RGNX is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 29, 2025
Stock price -- (FDMT: $3.34 vs. RGNX: $9.15)
Brand notoriety: FDMT and RGNX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FDMT: 42% vs. RGNX: 59%
Market capitalization -- FDMT: $154.65M vs. RGNX: $458.57M
FDMT [@Biotechnology] is valued at $154.65M. RGNX’s [@Biotechnology] market capitalization is $458.57M. The market cap for tickers in the [@Biotechnology] industry ranges from $272.78B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FDMT’s FA Score shows that 0 FA rating(s) are green whileRGNX’s FA Score has 1 green FA rating(s).

  • FDMT’s FA Score: 0 green, 5 red.
  • RGNX’s FA Score: 1 green, 4 red.
According to our system of comparison, RGNX is a better buy in the long-term than FDMT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FDMT’s TA Score shows that 5 TA indicator(s) are bullish while RGNX’s TA Score has 5 bullish TA indicator(s).

  • FDMT’s TA Score: 5 bullish, 3 bearish.
  • RGNX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, FDMT is a better buy in the short-term than RGNX.

Price Growth

FDMT (@Biotechnology) experienced а +9.15% price change this week, while RGNX (@Biotechnology) price change was +54.04% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +11.21%. For the same industry, the average monthly price growth was +1.12%, and the average quarterly price growth was -9.09%.

Reported Earning Dates

FDMT is expected to report earnings on Aug 07, 2025.

RGNX is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (+11.21% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RGNX($459M) has a higher market cap than FDMT($155M). RGNX YTD gains are higher at: 18.370 vs. FDMT (-40.036). FDMT has higher annual earnings (EBITDA): -181.14M vs. RGNX (-198.23M). FDMT has more cash in the bank: 425M vs. RGNX (235M). FDMT has less debt than RGNX: FDMT (24.6M) vs RGNX (82M). RGNX has higher revenues than FDMT: RGNX (83.3M) vs FDMT (37K).
FDMTRGNXFDMT / RGNX
Capitalization155M459M34%
EBITDA-181.14M-198.23M91%
Gain YTD-40.03618.370-218%
P/E RatioN/AN/A-
Revenue37K83.3M0%
Total Cash425M235M181%
Total Debt24.6M82M30%
FUNDAMENTALS RATINGS
RGNX: Fundamental Ratings
RGNX
OUTLOOK RATING
1..100
17
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
47
P/E GROWTH RATING
1..100
18
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FDMTRGNX
RSI
ODDS (%)
Bullish Trend 4 days ago
82%
Bearish Trend 4 days ago
75%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 4 days ago
83%
Momentum
ODDS (%)
Bullish Trend 4 days ago
75%
Bullish Trend 4 days ago
78%
MACD
ODDS (%)
Bullish Trend 4 days ago
73%
Bullish Trend 4 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 4 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
74%
Advances
ODDS (%)
Bullish Trend 7 days ago
79%
Bullish Trend 5 days ago
74%
Declines
ODDS (%)
Bearish Trend 21 days ago
90%
Bearish Trend 12 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
81%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
86%
View a ticker or compare two or three
Ad is loading...
FDMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA284.9525.44
+9.80%
Tesla
GME27.460.38
+1.40%
GameStop Corp
SPY550.643.95
+0.72%
SPDR® S&P 500® ETF
AAPL209.280.91
+0.44%
Apple
BTC.X93754.840000-892.085940
-0.94%
Bitcoin cryptocurrency

FDMT and

Correlation & Price change

A.I.dvisor indicates that over the last year, FDMT has been loosely correlated with STOK. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if FDMT jumps, then STOK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FDMT
1D Price
Change %
FDMT100%
+2.77%
STOK - FDMT
41%
Loosely correlated
-1.21%
IMNM - FDMT
41%
Loosely correlated
-1.41%
RGNX - FDMT
40%
Loosely correlated
-0.54%
RCKT - FDMT
39%
Loosely correlated
-2.69%
VTYX - FDMT
39%
Loosely correlated
-4.76%
More

RGNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RGNX has been loosely correlated with RCKT. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if RGNX jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RGNX
1D Price
Change %
RGNX100%
-0.54%
RCKT - RGNX
58%
Loosely correlated
-2.69%
DNLI - RGNX
55%
Loosely correlated
+1.23%
ARWR - RGNX
54%
Loosely correlated
-0.67%
NTLA - RGNX
52%
Loosely correlated
+1.59%
BEAM - RGNX
51%
Loosely correlated
-3.22%
More